Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Schmidt, Marcus; Fehm, Tanja; Liedtke, Cornelia et al.
News from ASCO 2017BREAST CARE. Bd. 12. H. 4. 2017 S. 266-268
Makris, G. M.; Chrelias, C.; Papanota, A. et al.
Ovarian tumors: Should the cervix be examined first?EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. Bd. 38. H. 3. 2017 S. 462-464
Finn, Richard S.; Crown, John; Lang, Istvan et al.
Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2-advanced breast cancer (PALOMA-1; TRIO-18).JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Ishibashi, Kei; Haber, Tobias; Breuksch, Ines et al.
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockadeONCOTARGET. Bd. 8. H. 33. 2017 S. 55230-55245
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionColloquium Senologie 2017/2018. München: Agileum Verlagsgesellschaft mbH 2017
Dinkic, C.; Eichbaum, M.; Schmidt, M. et al.
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant,recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialGYNECOLOGIC ONCOLOGY. Bd. 146. H. 2. 2017 S. 279-284
Barinoff, Jana; Schmidt, Marcus; Schneeweiss, Andreas et al.
Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgeryEUROPEAN JOURNAL OF CANCER. Bd. 83. 2017 S. 116-124
Almstedt, Katrin; Sicking, Isabel; Battista, Marco J. et al.
Prognostic Significance of Focal Adhesion Kinase in Node-Negative Breast CancerBREAST CARE. Bd. 12. H. 5. 2017 S. 329-333
Heimes, Anne-Sophie; Madjar, K.; Edlund, K. et al.
Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 143. H. 7. 2017 S. 1123-1131
Schmidt, M.; Madjar, K.; Heimes, A-S et al.
Prognostic significance of nuclear factor kappa B in node-negative breast cancer is most pronounced in luminal B breast cancerCANCER RESEARCH. Bd. 77. 2017